CIK 0001390478
- Non-accelerated filer
- Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-200-5278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $716,682
- in 3 filings
Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-04-13 | Hillsberg Sanford Director | Grant or award | +135,159 | 141,159 | ||
| 2011-03-31 | Ahn Mark J President and CEO | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2011-03-31 | Ahn Mark J President and CEO | Grant or award · Stock Option | +525,000 | 525,000 | ||
| 2011-03-25 | Nisi Rudolph Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2011-03-25 | Nisi Rudolph Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2011-03-25 | KRIEGSMAN STEVEN A Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2011-03-25 | KRIEGSMAN STEVEN A Director | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2011-03-25 | Hillsberg Sanford Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2011-03-25 | Hillsberg Sanford Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2011-03-25 | GALLIKER STEPHEN S Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2011-03-25 | Chin Richard Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2011-03-15 | Varanasi Ramani VP Business Development | Grant or award | +29,925 | 41,083 | ||
| 2011-03-15 | Tata Amy B Principlw Acctg Officer & Cont | Grant or award | +14,065 | 14,065 | ||
| 2011-03-15 | Pavco Pamela VP of Pharmaceutical Devlpmt | Grant or award | +33,563 | 44,940 | ||
| 2011-03-15 | Khvorova Anastasia Chief Science Officer | Grant or award | +43,053 | 60,559 | ||
| 2011-03-15 | Beerman Noah D CEO and President | Grant or award | +77,587 | 92,994 | ||
| 2011-01-13 | GALLIKER STEPHEN S Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2011-01-13 | KRIEGSMAN STEVEN A Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2011-01-13 | Nisi Rudolph Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2011-01-13 | Hillsberg Sanford Director | Grant or award · Stock Option | +50,000 | 50,000 |
Page 21 of 29 · 580 trades